Salicylic Acid
Also known as: BHA, Beta hydroxy acid, 2-Hydroxybenzoic acid
The oil-soluble exfoliant (BHA) that clears pores from the inside — the workhorse of acne skincare and the anti-acne OTC drug standard.

Salicylic acid is an established topical keratolytic used under U.S. OTC conditions for acne and warts. Concentration, vehicle, treated area, and directions matter, and evidence for consumer acne products should not be transferred to professional-strength peels.1, 4
- Oil-soluble BHA that exfoliates inside pores1, 4
- OTC acne standard: 0.5–2% in cleansers, toners, and spot treatments1, 4
- Also a keratolytic used for warts and dandruff at higher strengths1, 4
- Historically derived from willow bark; today produced synthetically1, 4
What is Salicylic Acid?
Salicylic acid's story begins with willow bark, whose pain-relieving and fever-reducing properties led to aspirin (acetylsalicylic acid). In skincare, it is used as an exfoliant with a unique twist: being oil-soluble, it travels through sebum to work inside the pore, breaking down the glue between dead skin cells where most water-based actives never reach. That makes it the standard first-line OTC ingredient for blackheads, whiteheads, and mild acne.3, 1
Where it comes from
Natural sources
- Willow bark and wintergreen leaves (historical sources of salicin/salicylic acid)
How it's made
Modern cosmetic and pharmaceutical salicylic acid is synthesized chemically.
What it does in products
Benefits
Clearing blackheads and whiteheads
strong evidenceTreating mild inflammatory acne
strong evidenceSkin texture and oil control
moderate evidenceEvidence scope and limitations
The review covers topical salicylic acid used under U.S. OTC acne and wart-remover conditions; cosmetic exfoliation and medical-strength peels are not treated as the same exposure.
- Concentration, vehicle, treated surface area, and occlusion materially change absorption and irritation.
- Evidence for OTC acne concentrations cannot be transferred to professional chemical peels.
Evidence last checked: 2026-09-26
Side effects & safety
Safety considerations
- Low-concentration topical use on small areas is generally considered acceptable, but many obstetric guidelines advise avoiding salicylic acid peels and large-area application during pregnancy. Ask your provider.
- Combining with retinoids, benzoyl peroxide, or AHAs increases irritation — split them across days or day/night.
- Increases sun sensitivity; daily sunscreen is recommended.
- Not for: Aspirin/NSAID allergy (caution), broken or infected skin
Amounts studied & product use
These figures describe research or common product use, not a personal dose or treatment recommendation.
In skincare studies and products
The FDA OTC acne monograph covers 0.5–2% salicylic acid; wart products use substantially higher monograph concentrations for a different indication. Professional peel evidence and wart-treatment strengths should not be transferred to daily facial cosmetics.
Regulatory status
- Salicylic acid is an FDA OTC monograph drug ingredient for acne (0.5–2%) and for wart removal (10–40%). In general cosmetics it is used under the FD&C Act.
- INCI name on cosmetic labels: Salicylic Acid.
- The CIR Expert Panel has assessed salicylic acid as safe in cosmetics within concentration limits.
BHA vs AHA: which one do you need?
Both are chemical exfoliants, but they specialize differently. BHAs (salicylic acid) are oil-soluble and penetrate pores — ideal for blackheads, oily skin, and breakouts. AHAs (glycolic, lactic) are water-soluble surface exfoliants — better for dullness, texture, and dry skin. Combination skin often benefits from alternating both, while sensitive skin should choose one at a low concentration.
3, 1Frequently asked questions
How often should I use salicylic acid?
Start with two to three nights per week and increase to nightly or every other night if tolerated. Wash-off products (cleansers) can be used daily with less risk, but leave-on formulas deliver more of the active.1, 4
The bottom line
Salicylic acid has clear, use-specific evidence for acne and warts. More concentrated or more frequent use increases irritation without guaranteeing a better result.
References
- Rulemaking history for OTC acne drug products. U.S. Food and Drug Administration (2025) · government guidance
- OTC Monograph M028: Wart Remover Drug Products for Over-the-Counter Human Use. U.S. Food and Drug Administration (2021) · government guidance · OTC Monograph M028
- Management of acne vulgaris: a review. JAMA (2021) · other · PMID 34812859
- Guidelines of care for the management of acne vulgaris. Journal of the American Academy of Dermatology (2024) · clinical guideline · PMID 38300170
- Topical treatments for cutaneous warts. Cochrane Database of Systematic Reviews (2012) · systematic review · PMID 22972052
Revision history
- Replaced search-result citations with exact sources, mapped claims to evidence, and reassessed evidence strength.